Solid Dosage
With our comprehensive portfolio of oral solid dosage solutions, we can supply full process lines with containment — from powder to coated tablet — including interfaces for powders, APIs and excipient dispensing, dry milling, powder collection, blending and more.
Steroids, endogenous hormones such as estrogen and testosterone and the adrenal cortex hormones, cortisol and aldosterone, play a key role in metabolic processes and have a number of pharmaceutical applications, including contraception, hormone therapy, antirheumatic, antiarthritic and bodybuilding preparations.
Predominantly used in global hormone replacement therapy, the three major segments comprise estrogen, growth and thyroid hormone, and testosterone replacement therapy. A major market driver is the increased awareness of postmenopausal hazards amongst women; others include an aging population, innovative drug delivery systems and the pharmerging economies.
Occupational steroid exposure can occur when the active ingredients are inhaled, ingested or absorbed through exposed skin. Although exposure can occur at any point in the production process, the greatest potential for worker exposure during steroid/hormonal drug production occurs during weighing, material transfer, equipment loading or milling.
Nevertheless, unit operations such as blending, granulation, drying, tablet compression and coating can also present hazards. It can even occur in the packaging area, during sampling and quality control, the testing of raw materials, intermediates and finished products, and during maintenance and cleaning.
Manufacturers have the responsibility to protect their operators, particularly those working with potent and toxic compounds, and set defined areas or controls necessary to eliminate the risk of product cross-contamination on a case-by-case basis.
GEA can help you to achieve these goals. From facility design and layout, manufacturing process controls (including adherence to standard operating procedures) and environmental control systems (HVAC) to extraction systems, industrial hygiene solutions and fully integrated, end-to-end containment solutions. We can advise and assist you to determine what level of containment is required where and when, optimizing the manufacturing process and making it efficient, safe and cost-effective.
显示 4 个,共 30 个
GEA 创新的 CIP 理念可满足全方位的高标准要求。我们的专家可确保产品在每个工艺点的安全。我们的每一次升级都基于当地的情况和客户的具体要求,可为客户实现显著地成本节约。
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Competitively priced with short delivery times, BUCK® valves are fully GMP compliant, offer robust, free-oriented docking, a dust- and contamination-free interface, and quick and easy maintenance. And, with thousands of global implementations and 20 years of experience.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
To support community engagement, GEA offers employees one day of paid time off per year.
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.